المؤلفون: Jan Skoda, Dunbar P, Yiwen Li, Annette Vu, Kangning Liu, Jacob W. Vogel, György Hajnóczky, Erica L. Carpenter, Patrick Reynolds C, David M. Booth, Chen Ma, Scadden E, Nakamaru-Ogiso E, Ye Jc, Hogarty, Goldsmith Kc, Coku J, Pedrotty Mc

مصطلحات موضوعية: 0303 health sciences, biology, Chemistry, Endoplasmic reticulum, Cytochrome c, Cancer, Mitochondrion, medicine.disease, 3. Good health, Multiple drug resistance, 03 medical and health sciences, 0302 clinical medicine, Apoptosis, 030220 oncology & carcinogenesis, Neuroblastoma, Cancer cell, Cancer research, medicine, biology.protein, 030304 developmental biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::69b282a3d253d6d3a09ed64b2d1a4ab0
https://doi.org/10.1101/2021.03.01.433120

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Irwin MS; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Goldsmith KC; Department of Pediatrics, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA.

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Aug; Vol. 22 (6).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Neuroblastoma*/genetics , Neuroblastoma*/diagnosis , Neuroblastoma*/pathology , Neuroblastoma*/therapy , Biomarkers, Tumor*/genetics, Humans ; Risk Assessment/methods ; Prognosis

المؤلفون: Dhuse J; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Cash T; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Elges MS; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Department of Pediatrics, Division of Pediatric Critical Care Medicine, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA., Alazraki A; Department of Radiology, Division of Pediatric Radiology and Imaging, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA., Beer R; Department of Pediatrics, Pediatric Biostatistics Core at Emory University School of Medicine, Atlanta, Georgia, USA., Jergel A; Department of Pediatrics, Pediatric Biostatistics Core at Emory University School of Medicine, Atlanta, Georgia, USA., Goldsmith KC; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Hall M; Children's Hospital Association, Lenexa, Kansas, USA., Kamat PP; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Department of Pediatrics, Division of Pediatric Critical Care Medicine, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Oct; Vol. 71 (10), pp. e31205. Date of Electronic Publication: 2024 Jul 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Databases, Factual* , Neuroblastoma*/radiotherapy , 3-Iodobenzylguanidine*/therapeutic use , 3-Iodobenzylguanidine*/administration & dosage , Intensive Care Units, Pediatric*, Humans ; Child, Preschool ; Infant ; Child ; Male ; Female ; Retrospective Studies ; Adolescent ; Infant, Newborn ; Analgesia/methods ; Analgesia/statistics & numerical data ; Iodine Radioisotopes/therapeutic use ; Iodine Radioisotopes/administration & dosage ; Hypnotics and Sedatives/administration & dosage ; Hypnotics and Sedatives/therapeutic use ; Follow-Up Studies ; Prognosis ; Radiopharmaceuticals/therapeutic use ; Radiopharmaceuticals/administration & dosage

المؤلفون: Mittal K; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Cooper GW; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Lee BP; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Su Y; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Skinner KT; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Shim J; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Jonus HC; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Kim WJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doshi M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Almanza D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kynnap BD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Christie AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Yang X; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cowley GS; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Leeper BA; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Morton CL; Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA., Dwivedi B; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Lawrence T; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Rupji M; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Keskula P; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Meyer S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Clinton CM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bhasin M; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Crompton BD; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tseng YY; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Boehm JS; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ligon KL; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Murphy AJ; Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Merck & Co., Rahway, NJ, USA., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Spangle JM; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA., Rivera MN; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Mullen EA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Stegmaier K; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Goldsmith KC; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. william_hahn@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. william_hahn@dfci.harvard.edu., Hong AL; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. andrew.hong2@emory.edu.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA. andrew.hong2@emory.edu.; Winship Cancer Institute, Emory University, Atlanta, GA, USA. andrew.hong2@emory.edu.

المصدر: Communications biology [Commun Biol] 2024 Apr 08; Vol. 7 (1), pp. 426. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

مواضيع طبية MeSH: Wilms Tumor*/drug therapy , Wilms Tumor*/genetics , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/genetics , Hydrazines* , Triazoles*, Humans ; Exportin 1 Protein ; Active Transport, Cell Nucleus ; Karyopherins/genetics ; Karyopherins/metabolism ; Receptors, Cytoplasmic and Nuclear/genetics ; Receptors, Cytoplasmic and Nuclear/metabolism ; Cell Line, Tumor ; Apoptosis ; Neoplasm Recurrence, Local ; Doxorubicin/pharmacology ; ATPases Associated with Diverse Cellular Activities/metabolism ; Cell Cycle Proteins/metabolism

المؤلفون: Bagatell R; Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., DuBois SG; Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Naranjo A; Department of Pediatrics, University of Florida, Gainesville, Florida, USA., Belle J; Children's Oncology Group, Monrovia, California, USA., Goldsmith KC; Department of Pediatrics, Children's Healthcare of Atlanta Inc Aflac Cancer and Blood Disorders Center, Atlanta, Georgia, USA., Park JR; Department of Oncology, St Jude Children's Research Hospital Department of Oncology, Memphis, Tennessee, USA., Irwin MS; Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada.

مؤلفون مشاركون: COG Neuroblastoma Committee; Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Sep; Vol. 70 Suppl 6, pp. e30572. Date of Electronic Publication: 2023 Jul 17.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neuroblastoma*/pathology, Child ; Humans ; Medical Oncology ; Disease Progression

المؤلفون: Pilgrim AA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA., Jonus HC; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA., Ho A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA., Cole AC; Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA.; Department of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Shim J; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, The Children's Healthcare of Atlanta, Atlanta, Georgia., Goldsmith KC; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, The Children's Healthcare of Atlanta, Atlanta, Georgia.

المصدر: Oncoimmunology [Oncoimmunology] 2023 Aug 05; Vol. 12 (1), pp. 2240678. Date of Electronic Publication: 2023 Aug 05 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Neuroblastoma*/drug therapy , Neuroblastoma*/metabolism , YAP-Signaling Proteins* , Sialyltransferases*/metabolism, Humans ; Down-Regulation ; Homeodomain Proteins/metabolism ; Homeodomain Proteins/therapeutic use ; Immunotherapy/methods ; Animals

المؤلفون: Cash T; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, Georgia, USA., Jonus HC; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Tsvetkova M; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Sadanand A; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Lee JY; Laney Graduate School Cancer Biology Program, Emory University, Atlanta, Georgia, USA., Henry CJ; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, Georgia, USA.; Laney Graduate School Cancer Biology Program, Emory University, Atlanta, Georgia, USA., Aguilera D; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Harvey RD; Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, Georgia, USA.; Department of Hematology/Medical Oncology and Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA., Goldsmith KC; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, Georgia, USA.; Laney Graduate School Cancer Biology Program, Emory University, Atlanta, Georgia, USA.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Aug; Vol. 70 (8), pp. e30405. Date of Electronic Publication: 2023 May 09.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma, Ewing* , Neoplasms*/drug therapy , Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/etiology , Neuroectodermal Tumors, Primitive, Peripheral*, Humans ; Child ; Infant ; Child, Preschool ; Adolescent ; Young Adult ; Adult ; Topotecan ; Simvastatin/adverse effects ; Interleukin-6 ; Cyclophosphamide ; Maximum Tolerated Dose ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Lee JY; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Jonus HC; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Sadanand A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Branella GM; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Maximov V; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Suttapitugsakul S; School of Chemistry and Biochemistry and the Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA., Schniederjan MJ; Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA, USA., Shim J; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Ho A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Parwani KK; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Fedanov A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Pilgrim AA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Silva JA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Schnepp RW; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Doering CB; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Wu R; School of Chemistry and Biochemistry and the Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA., Spencer HT; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA., Goldsmith KC; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, GA, USA. Electronic address: kgoldsm@emory.edu.

المصدر: Cell reports. Medicine [Cell Rep Med] 2023 Jun 20; Vol. 4 (6), pp. 101091.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: Neuroblastoma*/therapy , Neuroblastoma*/pathology , Receptors, Chimeric Antigen*/genetics, Humans ; Child ; Animals ; Mice ; Immunotherapy ; Protein-Tyrosine Kinases

المؤلفون: Berko ER; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petach Tikva, Israel, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Witek GM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA., Matkar S; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Petrova ZO; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.; Yale Cancer Biology Institute, Yale University, West Haven, CT, USA., Wu MA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.; Yale Cancer Biology Institute, Yale University, West Haven, CT, USA., Smith CM; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.; Yale Cancer Biology Institute, Yale University, West Haven, CT, USA., Daniels A; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Kalna J; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Kennedy A; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Gostuski I; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA., Casey C; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Krytska K; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Gerelus M; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Pavlick D; Foundation Medicine, Inc, Cambridge, MA, USA., Ghazarian S; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Park JR; St. Jude Children's Research Hospital, Memphis, TN, USA., Marachelian A; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Goldsmith KC; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.; Seattle Children's Hospital, Seattle, WA, USA., Radhakrishnan R; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.; Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, USA., Lemmon MA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA. mark.lemmon@yale.edu.; Yale Cancer Biology Institute, Yale University, West Haven, CT, USA. mark.lemmon@yale.edu., Mossé YP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. mosse@chop.edu.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. mosse@chop.edu.

المصدر: Nature communications [Nat Commun] 2023 May 05; Vol. 14 (1), pp. 2601. Date of Electronic Publication: 2023 May 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Circulating Tumor DNA*/genetics , Lung Neoplasms*/genetics , Neuroblastoma*/drug therapy , Neuroblastoma*/genetics, Humans ; Aminopyridines/therapeutic use ; Anaplastic Lymphoma Kinase/genetics ; Drug Resistance, Neoplasm/genetics ; Lactams, Macrocyclic/therapeutic use ; Mutation ; Protein Kinase Inhibitors/therapeutic use